Janus-Inspired Core-Shell Structure Hydrogel Programmatically Releases Melatonin for Reconstruction of Postoperative Bone Tumor.
Wei HuangXiaoyue WuYifan ZhaoYanhua LiuBo ZhangMingxin QiaoZhou ZhuZhi-He ZhaoPublished in: ACS applied materials & interfaces (2023)
At present, surgery is one of the main treatments for bone tumor. However, the risk of recurrence and the large area of bone defects after surgery pose a great challenge. Therefore, a Janus-inspired core-shell structure bone scaffold was designed to achieve the self-programmed release of melatonin at different concentrations, clearing the residual tumor cells at early stage after resection and promoting bone repair later. The layered differential load designs inspired by Janus laid the foundation for the differential release of melatonin, where sufficient melatonin inhibited tumor growth as low dose promoted osteogenesis. Then, the automatically programmed delivery of melatonin is achieved by the gradient degradation of the core-shell structure. In the material characterization, scanning electron microscopy revealed the core-shell structure. The drug release experiment and in vivo degradation experiment reflected the programmed differential release of melatonin. In the biological experiment part, in vivo and in vitro experiments not only confirmed the significant inhibitory effect of the core-shell hydrogel scaffold on tumor but also confirmed its positive effect on osteogenesis. Our Janus-inspired core-shell hydrogel scaffold provides a safe and efficient means to inhibit tumor recurrence and bone repair after bone tumor, and it also develops a new and efficient tool for differential and programmed release of other drugs.
Keyphrases
- bone mineral density
- bone regeneration
- low dose
- drug delivery
- early stage
- soft tissue
- bone loss
- tissue engineering
- drug release
- high dose
- high resolution
- hyaluronic acid
- mass spectrometry
- single cell
- coronary artery disease
- radiation therapy
- percutaneous coronary intervention
- neoadjuvant chemotherapy
- atrial fibrillation